Research Article
The Potential Value of Near Patient Platelet Function Testing in PCI: Randomised Comparison of 600 mg versus 900 mg Clopidogrel Loading Doses
Table 2
Baseline demographics and haematological parameters in PCI patients randomized to 600 mg and 900 mg clopidogrel loading doses.
| | 600 mg group | 900 mg group | value |
| Age | 65 3.8 | 65.2 3.7 | .92 | % male | 70% | 63.30% | .78 | Weight | 81.8 5.6 | 81.3 5.5 | .86 | Aspirin dose | 80.4 11.3 | 81.3 11.4 | .88 | PCI performed | 16 (53%) | 19 (63%) | 1.00 | No sig. coronary disease | 4 (13%) | 1 (3%) | .35 | Smokers | 6 (20%) | 1 (3%) | .10 | Diabetics | 6 (20%) | 2 (7%) | .25 | Haematoma | 0 | 1 (3%) | 1.00 | Enzyme rise | 5 (17%) | 6 (20%) | .72 | Hb | 140 5.7 | 139 5.7 | .86 | Plt count | 235 23.7 | 240 23.7 | .68 | Haematocrit | 0.41 0.01 | 0.41 0.01 | .84 | e GFR | 70.4 5.4 | 70 5.3 | .88 | INR | 0.99 0.0 | 0.99 0.0 | .94 |
|
|